Burr Hole Ultrasound Study

Sponsor
Kepler University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT06134206
Collaborator
(none)
20
1
1
11.8
1.7

Study Details

Study Description

Brief Summary

Chronic subdural hematoma (CSDH) is commonly managed through burr hole evacuation. This study evaluates the feasibility of trans burr hole sonography as an alternative postoperative imaging modality.

A pilot study on 20 patients who underwent burr hole surgery for CSDH was therefore planned. Postoperative imaging included both CT and sonographic examinations through the burr hole. We assessed the ability to measure residual subdural fluid thickness sonographically compared to CT.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Trans-burr hole ultrasound
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
1 Group of 20 patients who all underwent the same examination1 Group of 20 patients who all underwent the same examination
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Evaluation of the Feasibility of Measuring Chronic Subdural Hematoma Thickness Via Trans-burrhole Ultrasound
Actual Study Start Date :
May 1, 2022
Actual Primary Completion Date :
Apr 18, 2023
Actual Study Completion Date :
Apr 24, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Burr hole sonography

Patients within this arm (only arm of the study) undergo burr hole sonography

Diagnostic Test: Trans-burr hole ultrasound
All ultrasound examinations were conducted alongside the routine postoperative CT scan between 3-7 days postoperatively. To minimize potential influences of the patient's head position on the distribution and thickness of the subdural fluid, we first carried out the CT scan with the patient and their head in a supine position. Immediately after the CT scan, the patient remained on the same examination bed, and burr hole ultrasound was performed in the identical supine position. The burr hole was centered in the image, with the outer table surrounding the burr hole displayed as a horizontal line. The content of the burr hole could be differentiated by its higher echogenicity from the subdural residual hematoma or residual fluid. The brain's surface and overlying leptomeninges, however, displayed higher echogenicity compared to the subdural fluid. The subdural hematoma's thickness was measured at its maximum extent.
Other Names:
  • TBUS
  • Trans-burr hole sonography
  • burr hole sonography
  • burr hole ultrasound
  • Outcome Measures

    Primary Outcome Measures

    1. cSDH thickness [1 measurement on day 3-7 postoperative]

      maximum extent of the hematoma (chronic subdural hematoma, CSDH) thickness under the burr hole in axial and coronal plane

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Burr hole surgery due to chronic subdural hematoma

    • Routine performance of an computed tomography scan within 3-7 days postoperative

    • Ability to give informed consent

    Exclusion Criteria:
    • Performance of prior craniotomy

    • Performance of prior revision surgery

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Neurosurgery, Kepler University Hospital Linz Upper Austria Austria 4020

    Sponsors and Collaborators

    • Kepler University Hospital

    Investigators

    • Principal Investigator: Harald Stefanits, MD, PhD, Department of Neurosurgery, Kepler University Hospital Linz, Austria

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Kepler University Hospital
    ClinicalTrials.gov Identifier:
    NCT06134206
    Other Study ID Numbers:
    • EC Nr. 1054/2022
    First Posted:
    Nov 18, 2023
    Last Update Posted:
    Nov 18, 2023
    Last Verified:
    Nov 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Kepler University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 18, 2023